EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MYC Overexpression Enhances Sensitivity to MEK Inhibition in Head and Neck Squamous Cell Carcinoma

Cuicui Yang, Xiaowu Pang, Shaolei Teng iD, Shamel Wilson, Xinbin Gu, Guiqin Xie iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26020588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Cuicui Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Pathology, Howard University, 600 W Street NW, Washington, DC 20059, USA. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Proto-Oncogene Proteins c-myc, Pyridones, Pyrimidinones. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, NIMHD NIH HHS, the American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MEK inhibitors, such as trametinib, have shown therapeutic potential in head and neck squamous cell carcinoma (HNSCC). However, the factors influencing cancer cell sensitivity and resistance to MEK inhibition remain poorly understood. In our study, we observed that MEK inhibition significantly reduced the expression of MYC, a transcription factor critical for the therapeutic response. MYC overexpression markedly enhanced the sensitivity of HNSCC cells to trametinib, as evidenced by delayed wound healing and reduced colony formation. Cell cycle analysis revealed that trametinib induced a G1 phase arrest, whereas MYC overexpression accelerated cell cycle progression, with a reduced induction of p27 and p21 and diminished decreases in E2F1 and phospho-Ser2/5 levels. Flow cytometry and protein analyses demonstrated that MYC overexpression amplified trametinib-induced apoptosis and DNA damage, as evidenced by elevated levels of pro-apoptotic markers (p53, cleaved PARP, and BIM) and γH2AX. In vivo xenograft models confirmed these findings, showing increased sensitivity to trametinib in MYC-overexpressing tumors. Moreover, MEK inhibition increased autophagy in HNSCC cells, a factor critical for therapeutic resistance. Inhibiting trametinib-induced autophagy further enhanced apoptotic cell death. These findings suggest that MYC expression and autophagy play crucial roles in HNSCC’s response to MEK inhibition. Combining trametinib with autophagy inhibition may improve therapeutic outcomes in HNSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Squamous Cell Carcinoma of Head and NeckProto-Oncogene Proteins c-mycPyridonesPyrimidinonesHead and Neck NeoplasmsProtein Kinase InhibitorsHumansCell Line, TumorAnimalsApoptosisMiceXenograft Model Antitumor AssaysAutophagyGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmMice, NudeCell Proliferation

Stichwörter der Autor:innen

HNSCCMEK inhibitionMYCautophagytrametinib

Substanzen

Proto-Oncogene Proteins c-mycPyridonestrametinibPyrimidinonesProtein Kinase InhibitorsMYC protein, human

Autor:innen und Institutionen

  • Department of Oral Pathology, Howard University, 600 W Street NW, Washington, DC 20059, USA.
  • Cancer Center, Howard University, 2041 Georgia Avenue NW, Washington, DC 20059, USA.
  • Department of Biology, Howard University, 415 College St. NW, Washington, DC 20059, USA.

ORCID-Profile: Shaolei Teng, Guiqin Xie

Förderung

  • NIDCR NIH HHS
  • NIMHD NIH HHS
  • the American Cancer Society
  • the National Institute of Health
  • the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS)
  • American Cancer Society Diversity in Cancer Research Institutional Development Grant at Howard University
  • Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS)
  • National Institute of Health

Zitieren

APA

Yang, C., Pang, X., Teng, S., Wilson, S., Gu, X., & Xie, G. (2025). MYC Overexpression Enhances Sensitivity to MEK Inhibition in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020588

Vancouver

Yang C, Pang X, Teng S, Wilson S, Gu X, Xie G. MYC Overexpression Enhances Sensitivity to MEK Inhibition in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020588

BibTeX
@article{Yang2025,
  author = {Yang, Cuicui and Pang, Xiaowu and Teng, Shaolei and Wilson, Shamel and Gu, Xinbin and Xie, Guiqin},
  title = {MYC Overexpression Enhances Sensitivity to MEK Inhibition in Head and Neck Squamous Cell Carcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26020588}
}
Kostenlos starten →